Optimizing treatment of complicated grief a randomized clinical trial

JAMA Psychiatry

Volumn 73, Issue 7, 2016, Pages 685-694

  Shear, M Katherine ^a   Reynolds, Charles F ^b   Simon, Naomi M ^c,d   Zisook, Sidney ^e,f,g   Wang, Yuanjia ^h   Mauro, Christine ^h   Duan, Naihua ^a   Lebowitz, Barry ^e   Skritskaya, Natalia ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^g Veterans Medical and Research Foundation   (United States)

^h Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; AGED; ARTICLE; CALIFORNIA; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; COMPLICATED GRIEF; CONTROLLED STUDY; CONVERSATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMOTIONAL DISORDER; FEMALE; GRIEF; GUIDED IMAGERY; HOSPITALIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MASSACHUSETTS; MEDICATION COMPLIANCE; MOTIVATION; MULTICENTER STUDY; NEW YORK; PATIENT COMPLIANCE; PENNSYLVANIA; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT; ADJUSTMENT DISORDERS; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; DEPRESSIVE DISORDER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOLOGY; TREATMENT OUTCOME;

ADJUSTMENT DISORDERS; ADULT; AGED; CITALOPRAM; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; GRIEF; HUMANS; MALE; MIDDLE AGED; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 84978175058     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.0892     Document Type: Article

References (37)

1. Kersting A, Brähler E, Glaesmer H, Wagner B. Prevalence of complicated grief in a representative population-based sample. J Affect Disord. 2011;131(1-3):339-343.
2. He L, Tang S, Yu W, Xu W, Xie Q, Wang J. The prevalence, comorbidity and risks of prolonged grief disorder among bereaved Chinese adults. Psychiatry Res. 2014;219(2):347-352.
3. Shear MK. Clinical practice.complicated grief. N Engl J Med. 2015;372(2):153-160.
4. Cozza SJ, Fisher JE, Mauro CM, et al. Performance of DSM-5 Persistent Complex Bereavement Disorder criteria in a community sample of bereaved military family members. Am J Psychiatry. In Press.
5. Shear K, Frank E, Houck PR, Reynolds CF III. Treatment of complicated grief: a randomized controlled trial. JAMA. 2005;293(21):2601-2608.
6. Shear MK, Wang Y, Skritskaya N, Duan N, Mauro C, Ghesquiere A. Treatment of complicated grief in elderly persons: a randomized clinical trial. JAMA Psychiatry. 2014;71(11):1287-1295.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
8. Prigerson HG, Maciejewski PK, Reynolds CF III, et al. Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res. 1995;59(1-2):65-79.
9. Bui E, Mauro C, Robinaugh DJ, et al. The structured clinical interview for complicated grief: reliability, validity, and exploratory factor analysis. Depress Anxiety. 2015;32(7):485-492.
10. Zisook S, Shuchter SR, Pedrelli P, Sable J, Deaciuc SC. Bupropion sustained release for bereavement: results of an open trial. J Clin Psychiatry. 2001;62(4):227-230.
11. Simon NM, Shear MK, Fagiolini A, et al. Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief. Psychiatry Res. 2008;159(1-2):31-36.
12. Hensley PL, Slonimski CK, Uhlenhuth EH, Clayton PJ. Escitalopram: an open-label study of bereavement-related depression and grief. J Affect Disord. 2009;113(1-2):142-149.
13. Simon NM. Treating complicated grief. JAMA. 2013;310(4):416-423.
14. Guy W. Clinical Global Impressions. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976:218-222.
15. First MB Sr, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
16. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277.
17. Hafner J, Marks I. Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. Psychol Med. 1976;6(1):71-88.
18. Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461-464.
19. Shear K, Monk T, Houck P, et al. An attachment-based model of complicated grief including the role of avoidance. Eur Arch Psychiatry Clin Neurosci. 2007;257(8):453-461.
20. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583.
21. Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. 1996;5(3):215-238.
22. National Research Council of the National Academies. The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: National Academies Press; 2010.
23. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278-295.
24. Little RJ, D'Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355-1360.
25. SAS Institute Inc. Base SAS 9.3 Procedures Guide: Statistical Procedures. Cary, North Carolina: SAS Institute Inc; 2011.
26. Szanto K, Prigerson H, Houck P, Ehrenpreis L, Reynolds CF III. Suicidal ideation in elderly bereaved: the role of complicated grief. Suicide Life Threat Behav. 1997;27(2):194-207.
27. Latham AE, Prigerson HG. Suicidality and bereavement: complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide Life Threat Behav. 2004;34(4):350-362.
28. Szanto K, Shear MK, Houck PR, et al. Indirect self-destructive behavior and overt suicidality in patients with complicated grief. J Clin Psychiatry. 2006;67(2):233-239.
29. Rosner R, Pfoh G, Kotoucová M. Treatment of complicated grief [published online November 14, 2011]. Eur J Psychotraumatol.
30. Shear MK, Frank E, Foa E, et al. Traumatic grief treatment: a pilot study. Am J Psychiatry. 2001;158(9):1506-1508.
31. Kersting A, Dölemeyer R, Steinig J, et al. Brief internet-based intervention reduces posttraumatic stress and prolonged grief in parents after the loss of a child during pregnancy: a randomized controlled trial. Psychother Psychosom. 2013;82(6):372-381.
32. Litz BT, Schorr Y, Delaney E, et al. A randomized controlled trial of an internet-based therapist-assisted indicated preventive intervention for prolonged grief disorder. Behav Res Ther. 2014;61:23-34.
33. Wagner B, Knaevelsrud C, Maercker A. Internet-based cognitive-behavioral therapy for complicated grief: a randomized controlled trial. Death Stud. 2006;30(5):429-453.
34. Papa A, Sewell MT, Garrison-Diehn C, Rummel C. A randomized open trial assessing the feasibility of behavioral activation for pathological grief responding. Behav Ther. 2013;44(4):639-650.
35. ∗D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
36. Zisook S, Shear K. Grief and bereavement: what psychiatrists need to know. World Psychiatry. 2009;8(2):67-74.
37. Shear MK. Getting straight about grief. Depress Anxiety. 2012;29(6):461-464.